Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis

Andrea Péter1, Ágnes Balogh2, Szabolcs Szilágyi2

  • 1From the Institute of Cardiology, and the Institute of Internal Medicine, University of Debrecen, Debrecen; Heart Institute, University of Pécs, Pécs, Hungary; Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK.A. Péter, MD; Á. Balogh, MD, PhD, Institute of Cardiology, University of Debrecen; S. Szilágyi, MD, PhD, Cardiothoracic Centre, Freeman Hospital; R. Faludi, MD, PhD, Heart Institute, University of Pécs; M. Nagy-Vincze, MD, Institute of Internal Medicine, University of Debrecen; I. Édes, MD, PhD, DSc, Institute of Cardiology, University of Debrecen; K. Dankó, MD, PhD, DSc, Institute of Internal Medicine, University of Debrecen. doktorpandi@gmail.com.

Abstract

Insights

Early cardiac abnormalities in polymyositis (PM) and dermatomyositis (DM) were identified using tissue Doppler imaging (TDI). While systolic dysfunction improved with therapy, diastolic dysfunction worsened over three months.

Area of Science:

  • Cardiology
  • Rheumatology
  • Medical Imaging

Background:

  • Polymyositis (PM) and dermatomyositis (DM) are inflammatory myopathies that can affect the heart.
  • Early detection of cardiac involvement is crucial for patient management.
  • Conventional echocardiography may not always detect subtle cardiac abnormalities in these conditions.

Purpose of the Study:

  • To identify early echocardiographic abnormalities in patients with PM and DM at diagnosis.
  • To monitor changes in cardiac function during the first three months of therapy.
  • To evaluate the utility of tissue Doppler imaging (TDI) in detecting these abnormalities.

Main Methods:

  • Thirty patients diagnosed with PM/DM and no cardiovascular symptoms were included.
  • Age-matched healthy individuals served as controls.
  • Both traditional echocardiography and tissue Doppler imaging (TDI) were used to assess systolic and diastolic cardiac function.

Main Results:

  • TDI revealed early left and right ventricular systolic dysfunction at diagnosis, which improved significantly by three months of therapy.
  • Diastolic dysfunction, however, showed a deteriorating trend at the three-month follow-up.
  • Echocardiographic values for systolic function in patients approached those of the control group after therapy.

Conclusions:

  • Tissue Doppler imaging (TDI) is effective in detecting early cardiac abnormalities in PM/DM patients.
  • Therapy led to significant improvement in systolic cardiac dysfunction.
  • A notable deterioration in diastolic function was observed during the initial three months of treatment, highlighting the need for continued monitoring.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
473
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
1.4K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
633
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
814